Geron Corporation (Delaware)
GERN
Equity
ISIN null / Valor 145973
NASDAQ (2026-01-22)
USD 1.41+5.22%
Geron Corporation (Delaware)
UMushroom community rating:
About company
Geron Corporation (Delaware) is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of cancer.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
-52.8%1Y
-55.8%3Y
-18.5%5Y
Performance
74.4%1Y
79.3%3Y
76.1%5Y
Volatility
900 M
Market cap (USD)
11,479,201
Daily traded volume (Shares)
3.425 / 3.24
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
